Cargando…

Value of late gadolinium enhancement by magnetic resonance in patients with cardiac sarcoidosis: characteristic findings and clinical utility

Detalles Bibliográficos
Autores principales:	Watanabe, Eri, Kimura, Fumiko, Hiroe, Michiaki, Nakajima, Takatomo, Nakamura, Ayako, Nishii, Noriko, Kawana, Masatoshi, Hagiwara, Nobuhisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853845/ http://dx.doi.org/10.1186/1532-429X-11-S1-P260

Ejemplares similares

Can late gadolinium enhancement on cardiovascular magnetic resonance describe cardiac involvement in patients with systemic sarcoidosis and/or suspect of cardiac involvement of sarcoidosis with cardiac symptoms?
por: Kasai, Yufuko, et al.
Publicado: (2011)

Dose T2-weighted short TI inversion recovery images on cardiac magnetic resonance reflect disease activity in cardiac involvement of sarcoidosis patients?
por: Kasai, Yufuko, et al.
Publicado: (2012)

A case of cardiac sarcoidosis mimicking cardiac amyloidosis on cardiovascular magnetic resonance
por: Takemura, Kazunori, et al.
Publicado: (2018)

Magnetic resonance imaging of cardiac sarcoidosis: an evaluation of the cardiac segments and layers that exhibit late gadolinium enhancement
por: Komada, Tomohiro, et al.
Publicado: (2016)

Accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis
por: Tzogias, Leonidas, et al.
Publicado: (2009)

Right ventricle late gadolinium enhancement in cardiac sarcoidosis: a case series
por: Lydell, Carmen P, et al.
Publicado: (2011)

Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy
por: Sano, Makoto, et al.
Publicado: (2016)

Influence of late gadolinium enhancement on left ventricular morphology and function in patients with sarcoidosis
por: Patel, Amit R, et al.
Publicado: (2009)

Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women
por: Sekiguchi, Haruki, et al.
Publicado: (2017)

Bi-atrial fibrosis detected using three-dimensional late gadolinium enhancement magnetic resonance imaging in a patient with cardiac sarcoidosis(⋆)
por: Spence, Stewart, et al.
Publicado: (2018)

Late gadolinium enhancement and T2 MR imaging features of cardiac sarcoidosis involving the left and right ventricle
por: Cherian, Varghese, et al.
Publicado: (2009)

Refining risk assessment in cardiac sarcoidosis: a role for burden of late gadolinium enhancement and right ventricular function
por: Murtagh, Gillian, et al.
Publicado: (2014)

Prevalence and characteristics of myocardial crypts in Japanese patients referred for cardiovascular magnetic resonance
por: Watanabe, Eri, et al.
Publicado: (2015)

Utility of late gadolinium enhancement on magnetic resonance imaging in hypertrophic cardiomyopathy patients in an Indian cohort
por: Gangadharakaimal, Harikrishnan, et al.
Publicado: (2023)

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis
por: Lossnitzer, Dirk, et al.
Publicado: (2010)

Dressler's syndrome demonstrated by late gadolinium enhancement cardiovascular magnetic resonance
por: Steadman, Christopher D, et al.
Publicado: (2009)

Underdiagnosis of cardiac sarcoidosis by ECG and echocardiography in cases of extracardiac sarcoidosis
por: Ohira, Hiroshi, et al.
Publicado: (2022)

T2-weighted short-tau-inversion-recovery imaging reflects disease activity of cardiac sarcoidosis
por: Tonegawa-Kuji, Reina, et al.
Publicado: (2021)

Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis
por: Hulten, Edward, et al.
Publicado: (2016)

Regional extracellular volume within late gadolinium enhancement-positive myocardium to differentiate cardiac sarcoidosis from myocarditis of other etiology: a cardiovascular magnetic resonance study
por: Treiber, Julia, et al.
Publicado: (2023)

Prognostic utility of late gadolinium enhancement on cardiac magnetic resonance in cardiac amyloidosis: a meta-analysis
por: Raina, Sameer, et al.
Publicado: (2016)

Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance
por: Leyva, Francisco, et al.
Publicado: (2011)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

A Rare Case of Hypertrophic Cardiomyopathy with Subendocardial Late Gadolinium Enhancement in an Apical Aneurysm with Thrombus
por: Morita, Yusuke, et al.
Publicado: (2014)

What is the mid-wall linear high intensity “lesion” on cardiovascular magnetic resonance late gadolinium enhancement?
por: Nakamura, Masashi, et al.
Publicado: (2020)

Reconciling Q waves and late gadolinium enhancement with no angiographic evidence of coronary disease: cardiac sarcoidosis presenting as decompensated heart failure
por: MORRISSEY,, RYAN P, et al.
Publicado: (2010)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Pleural Sarcoidosis Visualized by Three-dimensional Computed Tomography
por: Katano, Takuma, et al.
Publicado: (2020)

Prognostic value of adenosine stress perfusion cardiac magnetic resonance with late gadolinium enhancement
por: Bertaso, Angela G, et al.
Publicado: (2011)

Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
por: Strijack, Bradford, et al.
Publicado: (2008)

Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance
por: Lopez, Javier E, et al.
Publicado: (2009)

Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance
por: Quail, Michael, et al.
Publicado: (2019)

Comparison of gadolinium dose and acquisition time for late gadolinium enhancement at 3.0 T
por: Doltra, Adelina, et al.
Publicado: (2014)

Direct Link Between Cardiac Failure and Global Cerebral Atrophy in a Young Adult: A Case Report on Reduced Cerebral Artery Blood Flow
por: Sekiguchi, Haruki, et al.
Publicado: (2023)

Pulmonary Follicular Lymphoma Showing Diffuse Micronodules Mimicking Sarcoidosis
por: Katano, Takuma, et al.
Publicado: (2018)

Imaging of Biliary Involvement in Sarcoidosis: Computed Tomography, Magnetic Resonance Cholangiopancreatography, and Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid-Enhanced Magnetic Resonance Imaging Findings
por: Renzulli, Matteo, et al.
Publicado: (2021)

Prognostic utility of late gadolinium enhancement cardiac magnetic resonance imaging in coronary artery disease: a meta-analysis
por: Chan, Raymond H, et al.
Publicado: (2013)

Detection of late radiation damage on left atrial fibrosis using cardiac late gadolinium enhancement magnetic resonance imaging
por: Huang, Y. Jessica, et al.
Publicado: (2016)

Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance
por: Kirk, Paul, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_eqgt2p6mgh6trrb925m140fgi0